Tech Company Financing Transactions
Cortria Funding Round
On 12/31/2008, Cortria raised $1.7 million in investment from Domain Associates and private investors.
Transaction Overview
Company Name
Announced On
12/31/2008
Transaction Type
Venture Equity
Amount
$1,699,900
Round
Undisclosed
Investors
Domain Associates (Brian Halak)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
45 School Street
Boston, MA 02108
USA
Boston, MA 02108
USA
Phone
Undisclosed
Website
Email Address
Overview
CortriaTM is a clinical-stage pharmaceutical company focused on developing safe and well-tolerated medicines to fight cardiovascular disease. CortriaTM is based in Boston, MA and backed by Domain Associates and MVM Life Science Partners.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Grau
Chief Scientific Officer
Dennis Giesing
Vice President
Eugenio Cefali
VP - Finance
Gregory Lumpkin
Browse more venture capital transactions:
Prev: 12/31/2008: XeroCoat venture capital transaction
Next: 12/31/2008: Infectious.com venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs